Diabetic Health Quote
Private Health Insurance
Diabetics Susceptible to Bladder Cancer

Thu, 19 Jan 2012

When St. Louis attorney Anthony Gray discovered that the U.S. Food and Drug Administration had warned that the long-term use of the drug Actos (pioglitazone) places diabetics at an increased risk of developing bladder cancer, he took particular note.

Once he knew that bladder cancer is related to type 2 diabetes, he instantly became highly concerned as he knew that diabetes has a disproportionate impact on the African-American community.

Many people will be affected. However, they are not aware of this.

Gray is an attorney with Johnson Gray. His firm is partnering with Kelley Law Group PC in Boston, along with the law firm Goldenberg Heller in Edwardsville, for securing compensation for damages incurred by bladder cancer patients who were taking Actos. Actos is manufactured by Japan's biggest drugmaker, Takeda Pharmaceutical.

The basis for the FDA warning is a five-year interim data analysis of a ten year study. A prior French study concluded that long-term use of Actos and higher cumulative doses considerably heightened the risk of bladder cancer. Germany does not permit new patients to use the drug.
add to favouritesnewsletterlink to this pagesend to friendpost comments

Link to this page

Copy and Paste the following HTML into your page.

ContentMain
newsnews rss